Q/C Technologies Overview
Q/C Technologies (QCLS) has a P/E ratio of -0.54, below the Healthcare sector average of 25.9.
Get informed when a big investor buys or sells
+ Follow-0.54
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Q/C Technologies's p/e ratio stands at -0.54. That is below the Healthcare sector average of 25.9. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Q/C Technologies sits lower the Healthcare benchmark (25.9) with a P/E ratio of -0.54. That is roughly 102.1% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether -0.54 is attractive depends on Q/C Technologies's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Q/C Technologies's P/E ratio evolved across reporting periods, while the comparison chart places QCLS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, P/E ratio is commonly used to spot outliers. Q/C Technologies's reading of -0.54 (sector avg 25.9) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
